JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2015, 64(6):276-278

Estimation of lipohydrophilic properties of molecules with potential β3-agonistic activity

Ľubica Havranová Sichrovská1,*, Lukáš Stanzel1, Ivan Malík1, Matej Maruniak1, Iva Kapustíková1, Eva Sedlárová1, Jozef Csӧllei2
1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Slovak Republic
2 Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic

Grants and funding:

This work was supported by the following Grant projects: FaF UK/29/2015, UK/346/2015, FaF UK/28/2015, FaF UK/44/2015, FaF UK/63/2015; Comenius University in Bratislava Science Park supported by the Research and Development Operational Programme funded by the ERDF - Grant number: ITMS 26240220086.

Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havranová Sichrovská Ľ, Stanzel L, Malík I, Maruniak M, Kapustíková I, Sedlárová E, Csӧllei J. Estimation of lipohydrophilic properties of molecules with potential β3-agonistic activity. Čes. slov. farm. 2015;64(6):276-278.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arnott J. A., Planey S. L. The influence of lipophilicity in drug discovery and design. Expert. Opin. Drug Discov. 2012; 10, 863-875. Go to original source... Go to PubMed...
    2. Testa B., Crivori P., Reist M., Carrupt P. A. The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples. Perspect. Drug. Discov. 2000; 19, 179-211. Go to original source...
    3. Brochard U. Pharmacolog ical properties of β-adrenoreceptor blocking drugs. J. Clin. Cardiol. 1998; 1, 5-9.
    4. Lechat P. Clinical pharmacolog y of beta-blockers in cardiolog y: trial results and clinical applications. Hot Topics Cardiol. 2008; 10, 7-44. Go to original source...
    5. Liu X., Testa B., Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm. Res. 2011; 10, 1401-1408. Go to original source... Go to PubMed...
    6. Sedlárová E., Čižmárik J. Štúdium lokálnych anestetík: časť 153. Vzťah medzi chemickou štruktúrou, fyzikálno-chemickými vlastnosťami a biolog ickou aktivitou v sérii piperidinopropylesterov alkoxysubstituovaných kyselín fenylkarbámových (In Slovak). Čes. slov. Farm. 2000; 49, 306-312.
    7. Arnott J. A., Kumar R., Lobo Planey S. Lipophilicity indices for drug developement. J. Appl. Biopharm. Pharmacokinet. 2013; 1, 31-36.
    8. Sedlárová E., Malík I., Andriamainty F., Kečkešová S., Csöӧllei J. Štúdium lipofility derivátov kyseliny fenylkarbámovej s bázickou časťou tvorenou substituovaným N-fenylpiperazínom(In Slovak). Farm. Obzor 2007; 4, 86-89.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.